TPG Capital To Buy Thycotic For $1.4B, Merge It With Rival Centrify: Report
The deal between TPG and privileged access management vendor Thycotic was signed Monday but has yet to close. It will lead to the private equity firm combining Thycotic with recently acquired rival Centrify. By Michael Novinson March 02, 2021, 11:19 AM EST
TPG Capital has agreed to purchase privileged access management (PAM) vendor Thycotic for $1.4 billion and combine it with recently acquired competitor Centrify, PE Hub reported.
The deal between San Francisco-based TPG and Washington, D.C.-based Thycotic was signed Monday but has yet to close, sources told PE Hub. Thycotic’s $1.4 billion valuation translates into an 11.6X revenue multiple, according to PE Hub, which reported last month that Thycotic generates $120 million in sales and is nearly even on earnings before interest, taxation, depreciation and amortization (EBITDA).
Centrify To Be Bought, Names Ex-Symantec Head Art Gilliland As CEO
Centrify will have its third owner and fourth top executive in less than three years after the privileged access management vendor agreed to be purchased by TPG and selected Art Gilliland as its next CEO. By Michael Novinson January 28, 2021, 02:08 PM EST
Centrify will have its third owner and fourth top executive in less than three years after the company agreed to be purchased by TPG and selected Art Gilliland as CEO.
The Santa Clara, Calif.-based privileged access management vendor on Thursday tapped Gilliland, the former head of Symantec Enterprise and CEO of Skyport Systems, to be its next leader. The move comes just seven months after Centrify brought in top CollabNet executive Flint Brenton to serve as its president and CEO. Gilliland will take over once TPG closes its acquisition of Centrify from Thoma Bravo.